Advancements in Molecular Profiling and Impact on Cancer Care
NOW on demand, Part 1 of 3 Caris Life Sciences Series. Host Shahid Shah sits down with Dr. James Hamrick to start the series with, “The Science”.
Why Long-Term Survivorship Demands Longitudinal Monitoring
By Erin Dickman DNP RN OCN – Cancer survivorship rates continue to grow, with the 5-year survival rate now reaching 70% across cancers. This is, of course, a source of hope for patients and families as they move forward after treatment.
Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care
By Charlotte Huff – For rural patients, getting cancer treatment close to home has always been difficult. But in recent years, chemotherapy deserts have expanded across the United States, with 382 rural hospitals halting services from 2014 to 2022, according to a report published this year by Chartis, a health analytics and consulting firm.
Improving Cancer Care Through Better Electronic Health Records
The Biden Cancer Moonshot aims to support and center patients and caregivers, and President Biden has made it clear that the American people deserve a health care system that they can rely on. That includes a system of electronic health records that gives patients and doctors the information they need to provide excellent patient care and improve outcomes.
The Myth of Value-Based Pricing for Cancer Drugs
By David Burda – Sometimes little studies say a lot about how the healthcare system works in the U.S. and why we need a customer revolution in healthcare. A great example is a recent two-page research letter in JAMA Internal Medicine.
CMS Proposes Physician Payment Rule to Expand Access to High-Quality Care
CMS issued the Calendar Year 2023 Physician Fee Schedule proposed rule, which would significantly expand access to behavioral health services, Accountable Care Organizations, cancer screening, and dental care – particularly in rural and underserved areas.
New Model to Improve Cancer Care for Medicare Patients
The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for Medicare & Medicaid Services, announced a new model aimed at improving cancer care for Medicare patients and lowering health care costs.
First Precision Medicine Platform to Resolve Complexities of Molecular Cancer Testing
Intervention Insights is pleased to announce the availability of Trapelo a true advancement in the use of molecular science and targeted therapies for cancer patients.
FDA Approves, CMS Proposes Coverage of First Test to Detect Extensive Number of Cancer Biomarkers
The U.S. Food and Drug Administration approved the FoundationOne CDx, the first breakthrough-designated, next generation sequencing (NGS)-based in vitro diagnostic test that can detect genetic mutations in 324 genes and two genomic signatures in any solid tumor type.
Astellas Oncology Finalists to Present Live at Stanford Medicine X
Astellas announced the five C3 Prize finalists chosen to present their ideas live at the Stanford Medicine X conference on Sept. 17 to a panel of judges including Robert Herjavec, dynamic entrepreneur, passionate cancer caregiver and star of ABC’s Emmy Award-winning television show, Shark Tank.
